5E. M. Leslie, R. G. Deeley,S. P. Cole. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense[J]. Toxicol Appl Pharmacoll, 2005, 204 (3) :216-237.
6E. Choong, M. Dobrinas, P. A. Carrupt, et al. The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution[J]. Expert Opin Drug Metab Toxicoll, 2010, 6 (8) :953-965.
7J. Ferte. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane[J]. Eur J Biocheml, 2000, 267 (2) :277-294.
8P. Kwan and M. J. Brodie. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy[J]. Epilepsial, 2005, 46 (2) :224-235.
9Y. Romsicki and F. J. Sharom. The ATPase and ATP-binding functions of P-glycoprotein—modulation by interaction with defined phospholipids[J]. Eur J Biocheml, 1998, 256 (1) :170-178.
